- Home
- DYN vs SPH Comparison
DYN vs SPH Comparison
Compare DYN & SPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DYN
- SPH
- Stock Information
- Founded
- DYN 1984
- SPH 1945
- Country
- DYN United States
- SPH United States
- Employees
- DYN N/A
- SPH N/A
- Industry
- DYN Medicinal Chemicals and Botanical Products
- SPH Other Specialty Stores
- Sector
- DYN Health Care
- SPH Consumer Discretionary
- Exchange
- DYN Nasdaq
- SPH Nasdaq
- Market Cap
- DYN 1.2B
- SPH 1.2B
- IPO Year
- DYN 2020
- SPH 1996
- Fundamental
- Price
- DYN $9.38
- SPH $18.49
- Analyst Decision
- DYN Strong Buy
- SPH Sell
- Analyst Count
- DYN 15
- SPH 1
- Target Price
- DYN $43.07
- SPH $17.00
- AVG Volume (30 Days)
- DYN 3.3M
- SPH 95.9K
- Earning Date
- DYN 08-11-2025
- SPH 08-07-2025
- Dividend Yield
- DYN N/A
- SPH 7.03%
- EPS Growth
- DYN N/A
- SPH N/A
- EPS
- DYN N/A
- SPH 1.46
- Revenue
- DYN N/A
- SPH $1,424,243,000.00
- Revenue This Year
- DYN N/A
- SPH $10.99
- Revenue Next Year
- DYN N/A
- SPH N/A
- P/E Ratio
- DYN N/A
- SPH $12.68
- Revenue Growth
- DYN N/A
- SPH 4.02
- 52 Week Low
- DYN $6.36
- SPH $15.20
- 52 Week High
- DYN $47.45
- SPH $22.24
- Technical
- Relative Strength Index (RSI)
- DYN 45.89
- SPH 49.34
- Support Level
- DYN $8.95
- SPH $18.20
- Resistance Level
- DYN $9.83
- SPH $18.69
- Average True Range (ATR)
- DYN 0.55
- SPH 0.30
- MACD
- DYN 0.17
- SPH 0.03
- Stochastic Oscillator
- DYN 74.58
- SPH 68.57
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.
About SPH Suburban Propane Partners L.P.
Suburban Propane Partners LP distributes propane, fuel oil, and other refined fuels to customers in the East Coast and West Coast regions of the United States. Other operations include natural gas and electricity marketing in the deregulated New York and Pennsylvania markets. The company operates in three segments: Propane; Fuel Oil and Refined Fuels; and Natural Gas and Electricity. It generates maximum revenue from Propane segment.